Author

M. Mattocks

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Assay:proteomics· 2 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

J. M. Powers· 2 shared R. S. Baric· 2 shared A. C. Walls· 1 shared A. Schäfer· 1 shared A. Seeger· 1 shared A. Valdez· 1 shared B. Dadonaite· 1 shared B. Pulendran· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

J. M. Powers

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination

W. N. Voss, M. A. Mallory, P. O. Byrne, J. M. Marchioni, S. A. Knudson, J. M. Powers, S. R. Leist, B. Dadonaite, D. R. Townsend, J. Kain, Y. Huang, E. Satterwhite, I. N. Castillo, M. Mattocks, C. Paresi, , G. C. Ippolito

This study compares IgG antibody responses from SARS-CoV-2 infection, vaccination, and hybrid immunity, finding that hybrid immunity retains the imprint of the initial exposure and enhances antibody breadth and affinity.

Cell Reports Medicine · Aug 1, 2024Peer-reviewedImmunology

Computationally designed mRNA-launched protein nanoparticle vaccines

G. G. Hendricks, L. Grigoryan, M. J. Navarro, N. J. Catanzaro, M. L. Hubbard, J. M. Powers, M. Mattocks, C. Treichel, A. C. Walls, J. Lee, D. Ellis, J. Y. Wang, S. Cheng, M. C. Miranda, A. Valdez, , N. P. King

This paper develops an mRNA-launched nanoparticle vaccine that combines protein nanoparticle and mRNA vaccine advantages, showing enhanced antibody and T cell responses in mice.

bioRxiv · Jul 22, 2024Immunology